Last reviewed 2026-06-01 · How we verify

Hello Cake ED Cake Meds

Aspargo Labs, Inc · Phase 2 active Small molecule ✓ Verified Jun 2026

Hello Cake ED Cake Meds is a Small molecule drug developed by Aspargo Labs, Inc. It is currently in Phase 2 development. Also known as: Sildenafil + Tadalafil (Hello Cake).

Hezkue, Hezkue Turbo, and Galotam are small molecule interventions being studied for the treatment of Erectile Dysfunction. These interventions are being evaluated in a Phase 2 clinical trial (NCT07231185) to assess their efficacy, safety, and treatment experience in adult men with Erectile Dysfunction.

Likelihood of approval

15.3% vs 15.3% industry baseline

If approved by FDA: likely 2031–2034

Steps remaining: Phase 3 → NDA/BLA submission

Confidence: Medium

Why this estimate

Baseline phase 2 → approval rate +15.3pp
Industry-wide phase 2 drugs reach approval ~15.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).

Predicted approval windows by jurisdiction (conditional on FDA approval)

Regulator	Country	Likely year	Lag vs FDA
FDA	US	2031–2034	—
EMA	EU	2032–2035	+0.7 yr
MHRA	GB	2032–2035	+0.7 yr
Health Canada	CA	2032–2036	+0.9 yr
TGA	AU	2032–2036	+1.2 yr
PMDA	JP	2032–2036	+1.5 yr
NMPA	CN	2033–2037	+2.3 yr
MFDS	KR	2032–2036	+1.4 yr
CDSCO	IN	2032–2037	+1.8 yr
ANVISA	BR	2033–2037	+2.3 yr

Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).

Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.

At a glance

Generic name	Hello Cake ED Cake Meds
Also known as	Sildenafil + Tadalafil (Hello Cake)
Sponsor	Aspargo Labs, Inc
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Hello Cake ED Cake Meds CI brief — competitive landscape report
Hello Cake ED Cake Meds updates RSS · CI watch RSS
Aspargo Labs, Inc portfolio CI

Frequently asked questions about Hello Cake ED Cake Meds

What is Hello Cake ED Cake Meds?

Hello Cake ED Cake Meds is a Small molecule drug developed by Aspargo Labs, Inc.

Who makes Hello Cake ED Cake Meds?

Hello Cake ED Cake Meds is developed by Aspargo Labs, Inc (see full Aspargo Labs, Inc pipeline at /company/aspargo-labs-inc).

Is Hello Cake ED Cake Meds also known as anything else?

Hello Cake ED Cake Meds is also known as Sildenafil + Tadalafil (Hello Cake).

What development phase is Hello Cake ED Cake Meds in?

Hello Cake ED Cake Meds is in Phase 2.

Manufacturer: Aspargo Labs, Inc — full pipeline
Also known as: Sildenafil + Tadalafil (Hello Cake)

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing